Maryland Gov. Wes Moore on Wednesday hosted his annual Pride month reception at Government House in Annapolis. “One of the ...

Gilead announced a deal to get its groundbreaking HIV prevention drug to lower income countries. Notably, the deal does not ...

It won't come to fruition for quite some time, but plans are afoot to create a Mount Gilead Park in Centreville's Historic District. Two representatives of the Fairfax County Park Authority ...

Gilead Sciences is laying off 36 people as part of a rethink that saw the Big Pharma scrap plans to expand a biologics facility in California. | Gilead is laying off 36 people as part of the ...

Gilead Sciences has blamed the low rate of respiratory syncytial virus (RSV) infections last season for ending two midstage trials of obeldesivir.

Gilead has been a leader in HIV innovation for decades. Now, we're proud to share that one of our researchers, Moupali Das, has been awarded the AAAS Mani L. Bhaumik Breakthrough of the Year Award for ...

Shares of Gilead rose 3% after the U.S. Supreme Court on Friday upheld a federal mandate that requires health insurers to cover preventive care services including those for reducing HIV risk and ...

See the latest Gilead Sciences GILD stock price (NASDAQ: GILD), related news, valuation, dividends and more to help you make your investing decisions.

“What could be an extraordinary game changer for HIV prevention is being completely undermined by Gilead’s greed. Charging $28,218 a year will drastically limit the availability of the drug.

The US Food and Drug Administration on Wednesday approved Gilead Sciences' twice-yearly injection to prevent HIV -- a move the company hailed as a major breakthrough in the fight against ...

Nonetheless, the firm concluded that Kymera’s partnerships with Sanofi and Gilead continue to “drive value.” ...

(RTTNews) - Gilead Sciences, Inc. (GILD) and Kymera Therapeutics, Inc. (KYMR) announced Wednesday that they have entered into an exclusive option and license agreement to accelerate the ...